These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Improved survival after lung transplantation in patients treated with tacrolimus/mycophenolate mofetil as compared with cyclosporine/azathioprine. Izbicki G; Shitrit D; Aravot D; Sulkes J; Saute M; Sahar G; Kramer MR Transplant Proc; 2002 Dec; 34(8):3258-9. PubMed ID: 12493439 [No Abstract] [Full Text] [Related]
12. Quantitative oropharyngeal Epstein-Barr virus shedding in renal and cardiac transplant recipients: relationship to immunosuppressive therapy, serologic responses, and the risk of posttransplant lymphoproliferative disorder. Preiksaitis JK; Diaz-Mitoma F; Mirzayans F; Roberts S; Tyrrell DL J Infect Dis; 1992 Nov; 166(5):986-94. PubMed ID: 1328412 [TBL] [Abstract][Full Text] [Related]
13. Population pharmacokinetics of cyclosporine: influence of covariables and assessment of cyclosporine absorption in kidney, lung, heart and heart + lung transplanted patients. Kyhl LE; Rasmussen SN; Aarons L; Jensen SB Transplant Proc; 1998 Aug; 30(5):1680. PubMed ID: 9723241 [No Abstract] [Full Text] [Related]
14. Clinical impact of Neoral in thoracic organ transplantation. Aziz T; el-Gamel A; Keevil B; Krysiak P; Campbell C; Rahman A; Deiraniya A; Yonan N Transplant Proc; 1998 Aug; 30(5):1900-3. PubMed ID: 9723326 [No Abstract] [Full Text] [Related]
15. Comparison of cyclosporine monitoring with trough levels to levels obtained 6 hours after the morning dose in heart transplant patients: a prospective randomized study. Cantarovich M; Latter D; Fitchett D Transplant Proc; 1997; 29(1-2):602-4. PubMed ID: 9123149 [No Abstract] [Full Text] [Related]
16. Impact of Sandimmune, Neoral, and Prograf on rejection incidence and renal function in primary liver transplant recipients. Van Buren D; Payne J; Geevarghese S; MacDonell R; Chapman W; Wright JK; Helderman JH; Richie R; Pinson CW Transplant Proc; 1998 Aug; 30(5):1830-2. PubMed ID: 9723299 [TBL] [Abstract][Full Text] [Related]
17. Benefits of mycophenolate mofetil in cardiac transplant recipients with cyclosporine-induced nephropathy. Sánchez V; Delgado JF; Blasco T; Dalmau R; Morales JM; Escribano P; Tello R; Hernández J; Velázquez T; Sotelo T; Gómez-Sánchez MA; Sáenz de la Calzada C Transplant Proc; 1999 Sep; 31(6):2515-6. PubMed ID: 10500695 [No Abstract] [Full Text] [Related]
18. Does early steroid withdrawal influence rejection and infection episodes during the first 2 years after heart transplantation? Seydoux C; Berguer DG; Stumpe F; Hurni M; Ruchat P; Fischer A; Müller X; Sadeghi H; Goy JJ Transplant Proc; 1997; 29(1-2):620-4. PubMed ID: 9123157 [No Abstract] [Full Text] [Related]
19. Effects of cyclosporine A monotherapy on the incidence of rejection and infection episodes in heart transplant patients. Seydoux C; Stumpe F; Hurni M; Ruchat P; Fischer A; Mueller X; von Segesser L; Goy JJ Transplant Proc; 1998 Dec; 30(8):4037-43. PubMed ID: 9865288 [No Abstract] [Full Text] [Related]